Form 4: Core Scientific CEO Adam Sullivan Reports Acquisition of Common Stock and RSU Grants

Sentiment:

SEC Form 4


Adam Sullivan, CEO of Core Scientific, reports the acquisition of common stock and grants of restricted stock units (RSUs) and performance-based RSUs (PSUs).

Summary

  • Adam Sullivan, the CEO of Core Scientific, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
  • On June 14, 2024, Sullivan acquired 2,867,521 shares of common stock through a special one-time restricted stock unit (RSU) grant.
  • He also acquired 716,881 shares through a regular annual RSU grant and 238,961 shares through a regular annual performance-based RSU (PSU) grant.
  • The reported amount of securities beneficially owned has been adjusted to reflect the acquisition of 45,160 shares of Common Stock that the Reporting Person received on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC.
  • Following these transactions, Sullivan beneficially owns 3,962,276 shares of Core Scientific common stock.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The grants suggest confidence in the CEO's continued service and performance, but there are no explicit positive or negative statements about the company's outlook.

Positives

  • The RSU and PSU grants align the CEO's interests with the long-term performance of the company.
  • The vesting schedules encourage continued service and achievement of performance goals.

Risks

  • The vesting of PSUs is contingent on achieving certain stock price hurdles, which may not be met.
  • If the CEO leaves the company before the RSUs and PSUs fully vest, a portion of the grants may be forfeited.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs and PSUs suggest an expectation of continued service and performance by the CEO.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • RSU and PSU grants are common compensation tools used by publicly traded companies to incentivize executives.
  • Vesting schedules and performance metrics vary depending on the company and industry.
  • Comparing the size and vesting terms of these grants to those of executives at comparable companies (e.g., Marathon Digital Holdings, Riot Platforms) would provide further context.

Stakeholder Impact

  • The RSU and PSU grants align the CEO's interests with those of shareholders, potentially leading to increased shareholder value.
  • Employees may be indirectly impacted by the CEO's performance, which could affect company culture and job security.

Key Dates

DateDescription
April 3, 2024Reporting Person received 45,160 shares of Common Stock for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC.
January 23, 2024Start date for vesting of special one-time RSU grant.
June 14, 2024Date of the reported transactions, including RSU and PSU grants.
January 23, 2025Start date for vesting of regular annual RSU grant.
2024, 2025, 2026Vesting years for the regular annual performance-based RSU (PSU) grant.
06/17/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.